Belite Bio (BLTE) Tops Q1 EPS by 10c

Belite Bio (NASDAQ: BLTE) reported Q1 EPS of ($0.27), $0.10 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
• AIAI Holdings extends lock-up agreements, pushing share release to 2027